Lyle Camblos is the Head of Global Operations at Evestia Clinical. In this role, Lyle oversees the execution of all clinical trials and helps manage corporate growth, while developing strategy and plans for future expansion on the Executive Steering Committee.
Prior to merging Atlantic Research Group with Evestia Clinical, Lyle was the President and co-founder of Atlantic Research Group, and served as President of the Board of Directors of Pharmaceutical Service Network. In this role, Lyle managed finance and overall operations while mentoring team members on project management and clinical trial execution. He was the architect of ARG’s corporate business framework, and developed procedures and processes to manage growth while providing a guiding hand to ensure the company retained the welcoming and supportive atmosphere of an agile small business.
Prior to co-founding Atlantic Research Group, Lyle held positions in the clinical research industry, as varied as entry-level site management to clinical research associate and project manager: his career achievements include leadership roles in mid-sized and large multinational CROs.
Lyle’s clinical research expertise extends from novel agents in orphan status phase I trials to post-marketing safety, surveillance, and oversight, including some of the largest and most successful supportive care and chemotherapeutic products on the market today. His knowledge beyond oncology includes plasma derivatives, endocrinology, immunology, and inflammatory disease indications. Lyle earned his Bachelor of Arts in Economics at the Virginia Military Institute.
Partner With Us
When every decision matters, we make sure you get it right.
